Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P0US
|
||||
Former ID |
DNC011409
|
||||
Drug Name |
4-Chloro-6-nitro-2-piperazin-1-yl-quinoline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526278] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H13ClN4O2
|
||||
Canonical SMILES |
C1CN(CCN1)C2=NC3=C(C=C(C=C3)[N+](=O)[O-])C(=C2)Cl
|
||||
InChI |
1S/C13H13ClN4O2/c14-11-8-13(17-5-3-15-4-6-17)16-12-2-1-9(18(19)20)7-10(11)12/h1-2,7-8,15H,3-6H2
|
||||
InChIKey |
HADJVDJPSUSVPZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent serotonin transporter | Target Info | Inhibitor | [526278] | |
KEGG Pathway | Serotonergic synapse | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.